发明公开
EP3089977A1 NOVEL INDOLE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
审中-公开
新型INDOLDERIVATVERBINDUNG和药物成分，以便
- 专利标题： NOVEL INDOLE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
- 专利标题（中）： 新型INDOLDERIVATVERBINDUNG和药物成分，以便
-
申请号： EP15733170.3申请日： 2015-01-02
-
公开(公告)号： EP3089977A1公开(公告)日： 2016-11-09
- 发明人: LEE, Changsik , YANG, Hyun-Mo , KIM, Dohoon , BAE, Miseon , CHOI, Youngil , HA, Nina
- 申请人： Chong Kun Dang Pharmaceutical Corp.
- 申请人地址： 8 Chungjeong-ro Seodaemun-gu Seoul 03742 KR
- 专利权人： Chong Kun Dang Pharmaceutical Corp.
- 当前专利权人： Chong Kun Dang Pharmaceutical Corp.
- 当前专利权人地址： 8 Chungjeong-ro Seodaemun-gu Seoul 03742 KR
- 代理机构： D Young & Co LLP
- 优先权： KR20140000802 20140103
- 国际公布： WO2015102426 20150709
- 主分类号： C07D413/06
- IPC分类号： C07D413/06 ; A61K31/5377 ; A61P37/00 ; A61P3/10
摘要：
The present invention provides a novel indole derivative compound, an isomer thereof, a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof. The compound according to the present invention can selectively inhibit histone deacetylase (HDAC), and thus can be used to effectively treat a disease associated with histone deacetylase (HDAC) activity.
信息查询
